Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A. Ference, Alberico L. Catapano, Henry N. Ginsberg et al.|European Heart Journal|2017Cited by 3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyBørge G. Nordestgaard, Olov Wiklund, Robert A. Hegele et al.|European Heart Journal|2013Cited by 2.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, Henry N. Ginsberg, M. John Chapman et al.|European Heart Journal|2020Cited by 1.5k
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyOlov Wiklund, Éric Bruckert, Robert A. Hegele et al.|European Heart Journal|2014Cited by 1.1k
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis SocietyHenry N. Ginsberg, Alberico L. Catapano, Chris J. Packard et al.|European Heart Journal|2021Cited by 889